Company page

Maxcyte, Inc.

Maxcyte, Inc. (Ticker: MXCT) is a public company based in the United States, with a market capitalization of approximately $129.6 million. The company focuses on providing cell-engineering solutions to accelerate drug discovery and development. Maxcyte's innovative technology is designed to enhance the efficiency of biomanufacturing processes in the life sciences sector.